Inverness Counsel’s Eterna Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $299K | Hold |
4,035
| – | – | 0.02% | 157 |
|
|
2022
Q2 | $627K | Hold |
4,035
| – | – | 0.04% | 104 |
|
|
2022
Q1 | $2.48M | Hold |
4,035
| – | – | 0.11% | 60 |
|
|
2021
Q4 | $5.05M | Buy |
4,035
+3,990
| +8,867% | +$4.99M | 0.19% | 53 |
|
|
2021
Q3 | $127K | Buy |
45
+1
| +2% | +$2.82K | ﹤0.01% | 171 |
|
|
2021
Q2 | $240K | Buy |
+44
| New | +$240K | 0.01% | 157 |
|